BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Akcay IM, Katrinli S, Ozdil K, Doganay GD, Doganay L. Host genetic factors affecting hepatitis B infection outcomes: Insights from genome-wide association studies. World J Gastroenterol 2018; 24(30): 3347-3360 [PMID: 30122875 DOI: 10.3748/wjg.v24.i30.3347]
URL: https://www.wjgnet.com/1007-9327/full/v24/i30/3347.htm
Number Citing Articles
1
Julieta Trinks, Sebastián Marciano, Isabella Esposito, Alejandra Franco, Maria Florencia Mascardi, Manuel Mendizabal, Beatriz Livellara, Diego Arrigo, Pablo Calzetta, Claudia Vujacich, Diego Giunta, Adrián Gadano, Diego Flichman. The genetic variability of hepatitis B virus subgenotype F1b precore/core gene is related to the outcome of the acute infectionVirus Research 2020; 277: 197840 doi: 10.1016/j.virusres.2019.197840
2
Alexander J. Mentzer, Alexander T. Dilthey, Martin Pollard, Deepti Gurdasani, Emre Karakoc, Tommy Carstensen, Allan Muhwezi, Clare Cutland, Amidou Diarra, Ricardo da Silva Antunes, Sinu Paul, Gaby Smits, Susan Wareing, HwaRan Kim, Cristina Pomilla, Amanda Y. Chong, Debora Y. C. Brandt, Rasmus Nielsen, Samuel Neaves, Nicolas Timpson, Austin Crinklaw, Cecilia S. Lindestam Arlehamn, Anna Rautanen, Dennison Kizito, Tom Parks, Kathryn Auckland, Kate E. Elliott, Tara Mills, Katie Ewer, Nick Edwards, Segun Fatumo, Emily Webb, Sarah Peacock, Katie Jeffery, Fiona R. M. van der Klis, Pontiano Kaleebu, Pandurangan Vijayanand, Bjorn Peters, Alessandro Sette, Nezih Cereb, Sodiomon Sirima, Shabir A. Madhi, Alison M. Elliott, Gil McVean, Adrian V. S. Hill, Manjinder S. Sandhu. High-resolution African HLA resource uncovers HLA-DRB1 expression effects underlying vaccine responseNature Medicine 2024; 30(5): 1384 doi: 10.1038/s41591-024-02944-5
3
Alicja E. Grzegorzewska, Monika K. Świderska, Wojciech Marcinkowski, Adrianna Mostowska, Paweł P. Jagodziński. Polymorphism rs368234815 of interferon-λ4 gene and generation of antibodies to hepatitis B virus surface antigen in extracorporeal dialysis patientsExpert Review of Vaccines 2020; 19(3): 293 doi: 10.1080/14760584.2020.1745637
4
Nevin Varghese, Amry Majeed, Suraj Nyalakonda, Tina Boortalary, Dina Halegoua-DeMarzio, Hie-Won Hann. Review of Related Factors for Persistent Risk of Hepatitis B Virus-Associated Hepatocellular CarcinomaCancers 2024; 16(4): 777 doi: 10.3390/cancers16040777
5
Linghuan Wang, Binqi Li, He Zhao, Peixin Wu, Qingzhen Wu, Kang Chen, Yiming Mu. A systematic review and meta-analysis of endocrine-related adverse events associated with interferonFrontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.949003
6
Mei‐Hsuan Lee, Yu‐Han Huang. Editorial: genome‐wide association for developing chronic hepatitis B—authors’ replyAlimentary Pharmacology & Therapeutics 2020; 52(6): 1085 doi: 10.1111/apt.15994
7
Niraj James Shah, Mark M Aloysius, Neil Rohit Sharma, Kumar Pallav. Advances in treatment and prevention of hepatitis BWorld Journal of Gastrointestinal Pharmacology and Therapeutics 2021; 12(4): 56-78 doi: 10.4292/wjgpt.v12.i4.56
8
Xuan Xu, Qing-Ye Zhang, Xin-Yi Chu, Yuan Quan, Bo-Min Lv, Hong-Yu Zhang. Facilitating Antiviral Drug Discovery Using Genetic and Evolutionary KnowledgeViruses 2021; 13(11): 2117 doi: 10.3390/v13112117
9
Peter Block, Brianna Shinn, Christopher Roth, Laurence Needleman, Ernest Rosato, Hie-Won Hann. Vagaries of the Host Response in the Development of Hepatitis B-related Hepatocellular Carcinoma: A Case SeriesCurrent Cancer Therapy Reviews 2020; 16(3): 253 doi: 10.2174/1573394716666200129121051
10
Matthew Z. Dudley, Jennifer E. Gerber, Haley Budigan Ni, Madeleine Blunt, Taylor A. Holroyd, Bruce C. Carleton, Gregory A. Poland, Daniel A. Salmon. Vaccinomics: A scoping reviewVaccine 2023; 41(14): 2357 doi: 10.1016/j.vaccine.2023.02.009
11
Yu‐Han Huang, Shu‐Fen Liao, Seik‐Soon Khor, Yu‐Ju Lin, Hsuan‐Yu Chen, Ya‐Hsuan Chang, Yi‐Hsiang Huang, Sheng‐Nan Lu, Hye‐Won Lee, Wen‐Ya Ko, Claire Huang, Po‐Chun Liu, Yen‐Ju Chen, Ping‐Feng Wu, Hou‐Wei Chu, Pei‐Ei Wu, Katsushi Tokunaga, Chen‐Yang Shen, Mei‐Hsuan Lee. Large‐scale genome‐wide association study identifies HLA class II variants associated with chronic HBV infection: a study from Taiwan BiobankAlimentary Pharmacology & Therapeutics 2020; 52(4): 682 doi: 10.1111/apt.15887
12
Patricia T. Illing, Andy van Hateren, Rachel Darley, Nathan P. Croft, Nicole A. Mifsud, Samuel King, Lyudmila Kostenko, Mandvi Bharadwaj, James McCluskey, Tim Elliott, Anthony W. Purcell. Kinetics of Abacavir-Induced Remodelling of the Major Histocompatibility Complex Class I Peptide RepertoireFrontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.672737
13
Elizabeth Hamilton, Ling Yang, Alexander J. Mentzer, Yu Guo, Yiping Chen, Jun Lv, Robert Fletcher, Neil Wright, Kuang Lin, Robin Walters, Christiana Kartsonaki, Yingcai Yang, Sushila Burgess, Sam Sansome, Liming Li, Iona Y. Millwood, Zhengming Chen. Conventional and genetic risk factors for chronic Hepatitis B virus infection in a community-based study of 0.5 million Chinese adultsScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-16360-7
14
Haibing Gao, Xiangmei Wang, Huaxi Ma, Shenglong Lin, Dongqing Zhang, Wenjun Wu, Ziyuan Liao, Mengyun Chen, Qin Li, Minghua Lin, Dongliang Li. METTL16 regulates m6A methylation on chronic hepatitis B associated gene HLA-DPB1 involved in liver fibrosisFrontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.996245
15
Abdul Malik, Fahad Aldakheel, Syed Rabbani, Meshal Alshehri, Anis Ahmad Chaudhary, Musaed Alkholief, Aws Alshamsan. LCR based quick detection of hotspot G1896A mutation in patients with different spectrum of hepatitis BJournal of Infection and Public Health 2021; 14(5): 651 doi: 10.1016/j.jiph.2021.01.013
16
Niraj James Shah, Mark M Aloysius, Neil Rohit Sharma, Kumar Pallav. Advances in treatment and prevention of hepatitis BWorld Journal of Gastrointestinal Pharmacology and Therapeutics 2021; 12(4): 56 doi: 10.4292/wjg.v12.i4.56
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
17
Danilo Di Bona, Janardan P. Pandey, Anna Aiello, Massimo Bilancia, Giuseppina Candore, Calogero Caruso, Claudia Colomba, Giovanni Duro, Mattia Emanuela Ligotti, Luigi Macchia, Sergio Rizzo, Giulia Accardi. The immunoglobulin γ marker 17 allotype and KIR/HLA genes prevent the development of chronic hepatitis B in humansImmunology 2020; 159(2): 178 doi: 10.1111/imm.13133
18
Yu-Ju Chu, Hwai-I. Yang, Hui-Han Hu, Jessica Liu, Yu-Ling Lin, Chia-Ling Chang, Wen-Sheng Luo, Chin-Lan Jen, Chien-Jen Chen. HBV genotype-dependent association of HLA variants with the serodecline of HBsAg in chronic hepatitis B patientsScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-27570-y
19
Zhenhua Zhang, Changtai Wang, Zhongping Liu, Guizhou Zou, Jun Li, Mengji Lu. Host Genetic Determinants of Hepatitis B Virus InfectionFrontiers in Genetics 2019; 10 doi: 10.3389/fgene.2019.00696
20
Safar M. Alqahtani, Ali Altharawi, Alhumaidi Alabbas, Faisal Ahmad, Hassan Ayaz, Asia Nawaz, Sidra Rahman, Manal A. Alossaimi. System biology approach to identify the novel biomarkers in glioblastoma multiforme tumors by using computational analysisFrontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1364138
21
Mahmoud F. Dondeti, Mohamed S. Abdelkhalek, Hosam M El-Din Elezawy, Walaa F. Alsanie, Bassem M. Raafat, Amira M. Gamal-Eldeen, Roba M. Talaat. Association between interferon-gamma (IFN-γ) gene polymorphisms (+874A/T and +2109A/G), and susceptibility to hepatitis B viral infection (HBV)Journal of Applied Biomedicine 2022; 20(1): 37 doi: 10.32725/jab.2022.001
22
Guo-Qing Yin, Ke-Ping Chen, Xiao-Chun Gu. Heterogeneity of immune control in chronic hepatitis B virus infection: Clinical implications on immunity with interferon-α treatment and retreatmentWorld Journal of Gastroenterology 2022; 28(40): 5784-5800 doi: 10.3748/wjg.v28.i40.5784
23
Ganesh Selvaraj Duraisamy, Dattatry Bhosale, Ivana Lipenská, Ivana Huvarova, Daniel Růžek, Marc P. Windisch, Andrew D. Miller. Advanced Therapeutics, Vaccinations, and Precision Medicine in the Treatment and Management of Chronic Hepatitis B Viral Infections; Where Are We and Where Are We Going?Viruses 2020; 12(9): 998 doi: 10.3390/v12090998
24
Shulin Xia, Jiachen Ding, Zhenhua Zhang, Xu Li, Jianhe Gan, Xiaomin He. Cluster of Differentiation 24 Polymorphism Has No Significant Association with Chronic Hepatitis B Virus Infection in the Chinese Han Population: A Family-Based Association StudyInfection and Drug Resistance 2022; : 4837 doi: 10.2147/IDR.S368392
25
Bart van Hoek. Editorial: genome‐wide association studies for developing chronic hepatitis BAlimentary Pharmacology & Therapeutics 2020; 52(6): 1083 doi: 10.1111/apt.15960
26
María B Pisano, Cecilia G Giadans, Diego M Flichman, Viviana E Ré, María V Preciado, Pamela Valva. Viral hepatitis update: Progress and perspectives World Journal of Gastroenterology 2021; 27(26): 4018-4044 doi: 10.3748/wjg.v27.i26.4018
27
Fernando Cezar-dos-Santos, João Paulo Assolini, Nádia Calvo Martins Okuyama, Kelvinson Fernandes Viana, Karen Brajão de Oliveira, Eiko Nakagawa Itano. Unraveling the susceptibility of paracoccidioidomycosis: Insights towards the pathogen-immune interplay and immunogeneticsInfection, Genetics and Evolution 2020; 86: 104586 doi: 10.1016/j.meegid.2020.104586
28
Duaa W. Al-Sadeq, Sara A. Taleb, Roan E. Zaied, Sara M. Fahad, Maria K. Smatti, Balsam R. Rizeq, Asmaa A. Al Thani, Hadi M. Yassine, Gheyath K. Nasrallah. Hepatitis B Virus Molecular Epidemiology, Host-Virus Interaction, Coinfection, and Laboratory Diagnosis in the MENA Region: An UpdatePathogens 2019; 8(2): 63 doi: 10.3390/pathogens8020063
29
Sheng-Han Wang, Shiou-Hwei Yeh, Pei-Jer Chen. Unique Features of Hepatitis B Virus-Related Hepatocellular Carcinoma in Pathogenesis and Clinical SignificanceCancers 2021; 13(10): 2454 doi: 10.3390/cancers13102454
30
Hai Cheng, Yaoling Ouyang, Chengbin Li. Impact of IRGM gene promoter polymorphisms on susceptibility to chronic HBV infectionInternational Journal of Immunogenetics 2024; 51(3): 149 doi: 10.1111/iji.12661
31
Fang Chen, Netanel Tzarum, Ian A Wilson, Mansun Law. VH1-69 antiviral broadly neutralizing antibodies: genetics, structures, and relevance to rational vaccine designCurrent Opinion in Virology 2019; 34: 149 doi: 10.1016/j.coviro.2019.02.004
32
Jun Wu, Meihong Han, Jia Li, Xiaoli Yang, Dongliang Yang. Hepatitis B Virus InfectionAdvances in Experimental Medicine and Biology 2020; 1179: 71 doi: 10.1007/978-981-13-9151-4_4
33
Saeideh Ashouri, Seik-Soon Khor, Yuki Hitomi, Hiromi Sawai, Nao Nishida, Masaya Sugiyama, Yosuke Kawai, Nawarat Posuwan, Pisit Tangkijvanich, Piyawat Komolmit, Makoto Tsuiji, Vorasuk Shotelersuk, Yong Poovorawan, Masashi Mizokami, Katsushi Tokunaga. Genome-Wide Association Study for Chronic Hepatitis B Infection in the Thai PopulationFrontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.887121
34
Tawatchai Apidechkul. Seroprevalence and factors associated with hepatitis B virus infection among the hill tribe youths, northern ThailandBMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-3747-3
35
Kehui Liu, Liwen Chen, Gangde Zhao, Zhujun Cao, Fengdi Li, Lanyi Lin, Chuanwu Zhu, Qing Xie, Yumin Xu, Shisan Bao, Hui Wang. IPS-1 polymorphisms in regulating interferon response in HBV infectionBioScience Trends 2019; 13(2): 130 doi: 10.5582/bst.2018.01304
36
Mohammad Enamul Hoque Kayesh, Md Abul Hashem, Takahiro Sanada, Bouchra Kitab, Md Haroon Or Rashid, Lipi Akter, Sayeh Ezzikouri, Shuko Murakami, Shintaro Ogawa, Yasuhito Tanaka, Michinori Kohara, Kyoko Tsukiyama-Kohara. Characterization of innate immune response to hepatitis B virus genotype F acute infection in tree shrew (Tupaia belangeri) modelFrontiers in Virology 2022; 2 doi: 10.3389/fviro.2022.926831
37
Anran Tian, Yuwen Li, Haozhi Fan, Pingping Hu, Ruirui Xu, Hui Yuan, Jinyuan Cai, Wen Zhang, Ming Yue, Jun Li, Chen Dong, Chuanlong Zhu. Association of Elongation Factor Tu GTP-binding Domain-containing 2 Gene (EFTUD2) Polymorphism with the Risk of Hepatitis B Virus InfectionImmunological Investigations 2022; 51(5): 1485 doi: 10.1080/08820139.2021.1970763
38
Béatrice Laupèze, Ventzislav Vassilev, Selim Badur. A role for immune modulation in achieving functional cure for chronic hepatitis B among current changes in the landscape of new treatmentsExpert Review of Gastroenterology & Hepatology 2023; 17(11): 1135 doi: 10.1080/17474124.2023.2268503
39
Magda Rybicka, Anna Woziwodzka, Alicja Sznarkowska, Tomasz Romanowski, Piotr Stalke, Marcin Dręczewski, Eloi R. Verrier, Thomas F. Baumert, Krzysztof Piotr Bielawski. Liver Cirrhosis in Chronic Hepatitis B Patients Is Associated with Genetic Variations in DNA Repair Pathway GenesCancers 2020; 12(11): 3295 doi: 10.3390/cancers12113295
40
Kwesi Z Tandoh, Osbourne Quaye. Genetic Associations in Chronic Hepatitis B Infection: Toward Developing Polygenic Risk ScoresFuture Microbiology 2022; 17(7): 541 doi: 10.2217/fmb-2021-0176
41
Ambika Sharma, Ajay Duseja, Jyoti Parkash, Harish Changotra. Association of IRGM gene promoter polymorphisms with hepatitis B virus infectionThe Journal of Gene Medicine 2022; 24(7) doi: 10.1002/jgm.3433
42
Jiamin Qiu, Shiwen Zhang, Yonghui Feng, Xin Su, Jun Cai, Shiyun Chen, Jiazi Liu, Shiqi Huang, Haokun Huang, Sui Zhu, Huiyan Wen, Jiaxin Li, Haoyu Yan, Zhiquan Diao, Xiaofeng Liang, Fangfang Zeng. Efficacy and safety of hepatitis B vaccine: an umbrella review of meta-analysesExpert Review of Vaccines 2024; 23(1): 69 doi: 10.1080/14760584.2023.2289566